SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-013194
Filing Date
2022-06-21
Accepted
2022-06-21 16:18:13
Documents
1
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4290
  Complete submission text file 0001567619-22-013194.txt   5666
Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Curnutte John T (Reporting) CIK: 0001574589 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 221028342

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations